MedTrace Logo

INSTrUCT-SCI: INdependent Observational STUdy of Cell Transplantation in SCI

NCT03069404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2020-05-15

No results posted yet for this study

Summary

The investigation is a multi-year observational study following the completion of the open-label, single dose Phase I/II study involving transplantation of allogeneic HuCNS-SC cells into 12 subjects with thoracic spinal cord injury.

Subjects will be monitored at routine intervals for safety and preliminary efficacy for 5 years post-transplantation of the Phase I/II investigation CL-N02-SC.

Conditions

  • Spinal Cord Injuries

Sponsors & Collaborators

  • Foundation Wings For Life

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Armin Curt, MD · Universitätsklinik Balgrist

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03069404 on ClinicalTrials.gov